BioCryst Pharmaceuticals
Price & Volume
Stats
See moreOpen | $6.73 |
Previous Close | $6.75 |
Day Range | $6.70-$6.84 |
52W Range | $6-$11.31 |
Market Cap | $1.4B |
Shares Short | 39M |
Financials
See moreRevenue (12 Mos) | $599.8M |
Revenue Growth (YoY) | 36.1% |
Gross Profit (12 Mos) | $410.4M |
Diluted EPS | -$0.05 |
News
See moreYahoo Finance • 24 days ago
H.C. Wainwright Lifts PT on BioCryst Pharmaceuticals (BCRX) to $32 From $30
Yahoo Finance • last month
Catalyst Watch: Spotlight on the Fed, Costco earnings, and Nasdaq 100 additions
Yahoo Finance • last month
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
BioCryst Receives Early Termination of HSR Waiting Period for Astria Acquisition
About
CEO | Mr. Charles K. Gayer |
CFO | Mr. Babar Ghias |
Address | 4505 Emperor Boulevard, Durham, NC, United States, 27703 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 580 |
